​

Praxis Precision Medicines (PRAX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Praxis Precision Medicines Revenue Highlights

Latest Revenue (Y)

$2.45M

Latest Revenue (Q)

$302.00K

Main Segment (Y)

License

Praxis Precision Medicines Revenue by Period

Praxis Precision Medicines Revenue by Year

DateRevenueChange
2023-12-31$2.45M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Praxis Precision Medicines generated $2.45M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Praxis Precision Medicines Revenue by Quarter

DateRevenueChange
2024-09-30$302.00K-15.41%
2024-06-30$357.00K-17.17%
2024-03-31$431.00K-16.31%
2023-12-31$515.00K10.04%
2023-09-30$468.00K-40.08%
2023-06-30$781.00K14.35%
2023-03-31$683.00K100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Praxis Precision Medicines generated $302.00K in revenue during Q3 2024, up -15.41% compared to the previous quarter, and up 38.67% compared to the same period a year ago.

Praxis Precision Medicines Revenue Breakdown

Praxis Precision Medicines Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
License$2.40M$98.50M

Praxis Precision Medicines's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23
License$400.00K$400.00K$400.00K$500.00K$800.00K$700.00K

Praxis Precision Medicines's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License (100.00%).

Praxis Precision Medicines Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RVMDRevolution Medicines$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
MOLNMolecular Partners$7.04M$2.74M
CRNXCrinetics Pharmaceuticals$4.01M-
HCWBHCW Biologics$2.84M$426.42K
PRAXPraxis Precision Medicines$2.45M$302.00K
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
IMRXImmuneering--
ANTXAN2 Therapeutics--
PHVSPharvaris--
DYNDyne Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
ELVNEnliven Therapeutics--
EWTXEdgewise Therapeutics--
PEPGPepGen--

PRAX Revenue FAQ

What is Praxis Precision Medicines’s yearly revenue?

Praxis Precision Medicines's yearly revenue for 2023 was $2.45M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. PRAX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Praxis Precision Medicines’s quarterly revenue?

Praxis Precision Medicines's quarterly revenue for Q3 2024 was $302K, a -15.41% decrease from the previous quarter (Q2 2024), and a -35.47% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $357K, a -17.17% decrease from the previous quarter (Q1 2024), and a -54.29% decrease year-over-year (Q2 2023). PRAX's quarterly revenue for Q1 2024 was $431K, a -16.31% decrease from the previous quarter (Q4 2023), and a -36.90% decrease year-over-year (Q1 2023).

What is Praxis Precision Medicines’s revenue growth rate?

Praxis Precision Medicines's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

What are Praxis Precision Medicines’s revenue streams?

Praxis Precision Medicines's revenue streams in c 23 are License

What is Praxis Precision Medicines’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Praxis Precision Medicines was License. This segment made a revenue of $2.4M, representing 100.00% of the company's total revenue.